Quotient Sciences’ Post

“Using adaptive clin­ical trial designs in early development can help rapidly advance a fit-for-phase for­mulation to a POC-ready format, optimize performance of a drug product in re­sponse to emerging clinical data, and gain valuable data to inform the next stage of development.” Read the full article to understand the benefits #TranslationalPharmaceutics could have on your clinical development projects. #QuotientSciences

Last week, our President and Chief Science Officer – Bikash Chatterjee served as chair for a presentation on “Barriers and Opportunities for Using Prior Knowledge to Expedite Drug Development and Approval” at the 2024 #NIPTE conference in Washington, DC. The FDA is shifting gears with their new #PlatformDesignation and #AdvancedManufacturing guidance. 💡 Here’s what matters most: ✅ Use Your Knowledge: Clearly define where your team uses prior vs. platform knowledge in your regulatory strategy. ✅ Talk to the FDA: Don’t wait! Connect early and often to simplify your path and avoid extra development steps. ✅ Modeling is the Future: FDA and industry agree—modeling drives efficiency in drug development and manufacturing. ✅ Invest in Data: Build systems to manage the data and models behind your innovation. #FDAUpdates #DrugDevelopment #InnovationInMedicine

Improving The Clinical Trial Ecosystem: A Call To Stakeholder Alignment https://lnkd.in/edrwxW_U - By Rob Freishtat, MD, MPH In theory, all of the stakeholders in drug development — investors, scientists, regulators, and patients — share the common goal of creating safe and effective drugs.

🧬 Scientifically Bold Monday - Edition 10 🧬 We believe in making decisions based on sound science and published research. With our tools, you can rely on validated data to guide your drug discovery process—no guesswork, just informed choices. 🔬 Ready to make data-driven decisions in drug design? Learn more: https://lnkd.in/eqGCh49N #BioSolveIT #DrugDiscovery #MedicinalChemistry

#DigitalPathology is transforming the pace of drug discovery. Read our Clinical Insights paper and learn more! https://lnkd.in/eCvqPgey

In Case You Missed It! Our latest article on the future of controlled release formulations is a must-read! Learn about the cutting-edge advancements in excipient technology that are driving better patient outcomes and more efficient drug delivery systems. Authored by our scientists @MatthiasKnarr and True Rogers and published in Drug Development & Delivery this insightful article is a must read! Catch up now! 🔗 http://spr.ly/6040q3xli #PharmaNews #DrugDelivery #PatientCare #CRFormulations

The next era of drug development requires the next era of IRB submission technology. Our proprietary submission management system is easy to learn and supported by real people – making the IRB process as seamless as possible. Learn more about why you should #ThinkBRANY for your next study: https://lnkd.in/eNMm66Qv

📢 Exciting News for Pharma IQ's Clinical Trial Supply Forum! Join us as Libbi Rickenbacher, PhD from 4G Clinical and Harald van Weeren, PhD present on "Automated Precision: Real-time Insights for Enhanced Drug Conditions & Supply Management at Clinical Sites." Dive into cutting-edge insights and take your clinical supply strategy to the next level! 🗓️ Date & Time: Day 1, May 15th, at 10:15 a.m. Mark your calendars and be a part of this transformative discussion. We cannot wait to share our innovations with you! #ClinicalTrial #SupplyChain #BrusselsEvent

Have you ever wondered how a medicine makes it to market? The Path to Progress tells the story of the fascinating journey from drug discovery to approval; told by those who make it happen. Visit our website to hear #BMSUK colleagues discuss the complexity and teamwork involved in bringing a medicine to market: https://lnkd.in/ekp4B5eS #PathToProgress #drugdevelopment 

Ultimately, the goal of biotech leaders is to create an innovative product that brings medical value for patients. This cannot be achieved in a single step, and we help biotechs along the journey to reach that goal, structuring the drug development process into a series of clear and reachable value inflection points. Learn more about how we support our biotech clients or connect with our delegates onsite at #SwissBiotechDay: https://lnkd.in/dVAEZRKN #biotech #drugdevelopment